Improvement of ovarian response and oocyte quality of aged female by administration of bone morphogenetic protein-6 in a mouse model

Reproductive Biology and Endocrinology

Volumn 10, Issue , 2012, Pages

  Park, Seung S ^a   Park, Min J ^b   Joo, Bo S ^b   Joo, Jong K ^a   Son, Jung B ^a   Lee, Kyu S ^a  

^a Pusan National University School of Medicine   (South Korea)

^b Good Moonhwa Hospital   (South Korea)

Author keywords

BMP 6; Female aging; Id 1; Oocyte quality; Ovarian function; VEGF

Indexed keywords

BONE MORPHOGENETIC PROTEIN 6; CHORIONIC GONADOTROPIN; INHIBITOR OF DNA BINDING PROTEIN 1; PROTEIN INHIBITOR; RECOMBINANT BONE MORPHOGENETIC PROTEIN 6; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

AGED; AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLASTOCYST; CONTROLLED STUDY; EMBRYO; EMBRYO CULTURE; FEMALE; FEMALE INFERTILITY; HISTOPATHOLOGY; HORMONE RESPONSE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; OOCYTE DEVELOPMENT; OOCYTE RETRIEVAL; OVARY HYPERSTIMULATION; OVULATION INDUCTION; PROTEIN EXPRESSION; WESTERN BLOTTING; ZYGOTE;

AGING; ANIMALS; BONE MORPHOGENETIC PROTEIN 6; CELLS, CULTURED; FEMALE; INFERTILITY, FEMALE; INHIBITOR OF DIFFERENTIATION PROTEIN 1; MICE; MICE, INBRED C57BL; MODELS, ANIMAL; OOCYTES; OVARY; OVULATION INDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EQUIDAE; MUS;

EID: 84871536590     PISSN: None     EISSN: 14777827     Source Type: Journal    
DOI: 10.1186/1477-7827-10-117     Document Type: Article

References (42)

1. Navot D, Bergh PA, Williams MA, Garrisi GJ, Guzman I, Sandler B, Grunfeld L. Poor oocyte quality rather than implantation failure as a cause of age-related decline in female fertility. Lancet 1991, 337:1375-1377. 10.1016/0140-6736(91)93060-M, 1674764.
2. Tarin JJ, Perez-Albala S, Cano A. Cellular and morphological traits of oocytes retrieved from aging mice after exogenous ovarian stimulation. Biol Reprod 2001, 65:141-150. 10.1095/biolreprod65.1.141, 11420234.
3. Geva E, Jaffe RB. Role of vascular endothelial growth factor in ovarian physiology and pathology. Fertil Steril 2000, 74:429-438. 10.1016/S0015-0282(00)00670-1, 10973633.
4. Fraser HM. Regulation of the ovarian follicular vasculature. Reprod Biol Endocrinol 2006, 4:18. 10.1186/1477-7827-4-18, 1459163, 16611363.
5. Robinson RS, Woad KJ, Hammond AJ, Laird M, Hunter MG, Mann GE. Angiogenesis and vascular function in the ovary. Reproduction 2009, 138:869-881. 10.1530/REP-09-0283, 19786399.
6. Araújo VR, Duarte AB, Bruno JB, Pinho Lopes CA, de Figueiredo JR. Importance of vascular endothelial growth factor (VEGF) in ovarian physiology of mammals. Zygote 2011, 13:1-10.
7. Tatone C, Amicarelli F, Carbone MC, Monteleone P, Caserta D, Marci R, Artini PG, Piomboni P, Focarelli R. Cellular and molecular aspects of ovarian follicle ageing. Hum Reprod Update 2008, 14:131-142. 10.1093/humupd/dmm048, 18239135.
8. Knight PG, Glister C. TGF-beta superfamily members and ovarian follicle development. Reproduction 2006, 132:191-206. 10.1530/rep.1.01074, 16885529.
9. Shimasaki S, Moore RK, Otsuka F, Erickson GF. The bone morphogenetic protein system in mammalian reproduction. Endocr Rev 2004, 25:72-101. 10.1210/er.2003-0007, 14769828.
10. Dong J, Albertini DF, Nishimori K, Kumar TR, Lu N, Matzuk MM. Growth differentiation factor-9 is required during early ovarian folliculogenesis. Nature 1996, 383:531-535. 10.1038/383531a0, 8849725.
11. Edson MA, Nalam RL, Clementi C, Franco HL, Demayo FJ, Lyons KM, Pangas SA, Matzuk MM. Granulosa cell-expressed BMPR1A and BMPR1B have unique functions in regulating fertility but act redundantly to suppress ovarian tumor development. Mol Endocrinol 2010, 24:1251-1266. 10.1210/me.2009-0461, 2875809, 20363875.
12. Yi SE, Lapolt PS, Yoon BS, Chen JY, Lu JK, Lyons KM. The type I BMP receptor BmprIB is essential for female reproductive function. Proc Natl Acad Sci USA 2001, 98:7994-7949. 10.1073/pnas.141002798, 35456, 11416163.
13. Gode F, Gulekli B, Dogan E, Korhan P, Dogan S, Bige O, Cimrin D, Atabey N. Influence of follicular fluid GDF9 and BMP15 on embryo quality. Fertil Steril 2011, 95:2274-2278. 10.1016/j.fertnstert.2011.03.045, 21496799.
14. Otsuka F, Moore RK, Shimasaki S. Biological function and cellular mechanism of bone morphogenetic protein-6 in the ovary. J Biol Chem 2001, 276:32889-32895. 10.1074/jbc.M103212200, 11447221.
15. Shi J, Yoshino O, Osuga Y, Koga K, Hirota Y, Hirata T, Yano T, Nishii O, Taketani Y. Bone morphogenetic protein-6 stimulates gene expression of follicle-stimulating hormone receptor, inhibin/activin beta subunits, and anti-müllerian hormone in human granulosa cells. Fertil Steril 2009, 92:1794-1798. 10.1016/j.fertnstert.2009.05.004, 19539911.
16. Glister C, Richards SL, Knight PG. Bone morphogenetic proteins (BMP) -4, -6, and -7 potently suppress basal and luteinizing hormone-induced androgen production by bovine theca interna cells in primary culture: could ovarian hyperandrogenic dysfunction be caused by a defect in thecal BMP signaling?. Endocrinology 2005, 146:1883-1892. 10.1210/en.2004-1303, 15625241.
17. Hussein TS, Froiland DA, Amato F, Thompson JG, Gilchrist RB. Oocytes prevent cumulus cell apoptosis by maintaining a morphogenic paracrine gradient of bone morphogenetic proteins. J Cell Sci 2005, 118:5257-5268. 10.1242/jcs.02644, 16263764.
18. Juengel JL, Reader KL, Bibby AH, Lun S, Ross I, Haydon LJ, McNatty KP. The role of bone morphogenetic proteins 2, 4, 6 and 7 during ovarian follicular development in sheep: contrast to rat. Reproduction 2006, 131:501-513. 10.1530/rep.1.00958, 16514193.
19. Miyoshi T, Otsuka F, Inagaki K, Otani H, Takeda M, Suzuki J, Goto J, Ogura T, Makino H. Differential regulation of steroidogenesis by bone morphogenetic proteins in granulosa cells: involvement of extracellularly regulated kinase signaling and oocyte actions in follicle-stimulating hormone-induced estrogen production. Endocrinology 2007, 148:337-345.
20. Campbell BK, Souza CJ, Skinner AJ, Webb R, Baird DT. Enhanced response of granulosa and theca cells from sheep carriers of the FecB mutation in vitro to gonadotropins and bone morphogenic protein-2, -4, and -6. Endocrinology 2006, 147:1608-1620.
21. Campbell BK, Kendall NR, Baird DT. Effect of direct ovarian infusion of bone morphogenetic protein 6 (BMP-6) on ovarian function in sheep. Biol Reprod 2009, 81:1016-1023. 10.1095/biolreprod.109.076653, 19641181.
22. Sugiura K, Su YQ, Eppig JJ. Does bone morphogenetic protein 6 (BMP-6) affect female fertility in the mouse?. Biol Reprod 2010, 83:997-1004. 10.1095/biolreprod.110.086777, 2994326, 20702851.
23. Ren R, Charles PC, Zhang C, Wu Y, Wang H, Patterson C. Gene expression profiles identify a role for cyclooxygenase 2-dependent prostanoid generation in BMP-6-induced angiogenic responses. Blood 2007, 109:2847-2853. 1852219, 17119124.
24. Valdimarsdottir G, Goumans MJ, Rosendahl A, Brugman M, Itoh S, Lebrin F, Sideras P, ten Dijke P. Stimulation of Id1 expression by bone morphogenetic protein is sufficient and necessary for bone morphogenetic protein-induced activation of endothelial cells. Circulation 2002, 106:2263-2270. 10.1161/01.CIR.0000033830.36431.46, 12390958.
25. Hogg K, Etherington SL, Young JM, McNeilly AS, Duncan WC. Inhibitor of differentiation (Id) genes are expressed in the steroidogenic cells of the ovine ovary and are differentially regulated by members of the transforming growth factor-beta family. Endocrinology 2010, 151:1247-1256. 10.1210/en.2009-0914, 2971462, 20032053.
26. O'Toole PJ, Inoue T, Emerson L, Morrison IE, Mackie AR, Cherry RJ, Norton JD. Id proteins negatively regulate basic helix-loop-helix transcription factor function by disrupting subnuclear compartmentalization. J Biol Chem 2003, 278:45770-45706. 10.1074/jbc.M306056200, 12952978.
27. Johnson AL, Haugen MJ, Woods DC. Role for inhibitor of differentiation/deoxyribonucleic acid-binding (Id) proteins in granulosa cell differentiation. Endocrinology 2008, 149:3187-3195. 10.1210/en.2007-1659, 18325989.
28. Johnson AL, Woods DC. Dynamics of avian ovarian follicle development: cellular mechanisms of granulosa cell differentiation. Gen Comp Endocrinol 2009, 163:12-17. 10.1016/j.ygcen.2008.11.012, 19059411.
29. Barone MV, Pepperkok R, Peverali FA, Philipson L. Id proteins control growth induction in mammalian cells. Proc Natl Acad Sci USA 1994, 91:4985-4988. 10.1073/pnas.91.11.4985, 43914, 8197168.
30. Benezra R, Rafii S, Lyden D. The Id proteins and angiogenesis. Oncogene 2001, 20:8334-8341. 10.1038/sj.onc.1205160, 11840326.
31. Ling MT, Lau TC, Zhou C, Chua CW, Kwok WK, Wang Q, Wang X, Wong YC. Overexpression of Id-1 in prostate cancer cells promotes angiogenesis through the activation of vascular endothelial growth factor (VEGF). Carcinogenesis 2005, 26:1668-1676. 10.1093/carcin/bgi128, 15905202.
32. Hino J, Takao M, Takeshita N, Konno Y, Nishizawa T, Matsuo H, Kangawa K. cDNA cloning and genomic structure of human bone morphogenetic protein-3B (BMP-3b). Biochem Biophys Res Commun 1996, 223:304-310. 10.1006/bbrc.1996.0889, 8670277.
33. Erickson GF, Shimasaki S. The spatiotemporal expression pattern of the bone morphogenetic protein family in rat ovary cell types during the estrous cycle. Reprod Biol Endocrinol 2003, 1:9. 10.1186/1477-7827-1-9, 153494, 12741959.
34. Erickson GF, Fuqua L, Shimasaki S. Analysis of spatial and temporal expression patterns of bone morphogenetic protein family members in the rat uterus over the estrous cycle. J Endocrinol 2004, 182:203-217. 10.1677/joe.0.1820203, 15283681.
35. Stouffer RL, Martínez-Chequer JC, Molskness TA, Xu F, Hazzard TM. Regulation and action of angiogenic factors in the primate ovary. Arch Med Res 2001, 32:567-575. 10.1016/S0188-4409(01)00323-X, 11750732.
36. Kim HJ, Chung H, Yoo YG, Kim H, Lee JY, Lee MO, Kong G. Inhibitor of DNA binding 1 activates vascular endothelial growth factor through enhancing the stability and activity of hypoxia-inducible factor-1alpha. Mol Cancer Res 2007, 5:321-329. 10.1158/1541-7786.MCR-06-0218, 17426247.
37. Lee DH, Joo BS, Suh DS, Park JH, Choi YM, Lee KS. Sodium nitroprusside treatment during the superovulation process improves ovarian response and ovarian expression of vascular endothelial growth factor in aged female mice. Fertil Steril 2008, 89:1514-1521. 10.1016/j.fertnstert.2007.05.067, 18206874.
38. Joo JK, Joo BS, Kim SC, Choi JR, Park SH, Lee KS. Role of leptin in improvement of oocyte quality by regulation of ovarian angiogenesis. Anim Reprod Sci 2010, 119:329-334. 10.1016/j.anireprosci.2010.02.002, 20197222.
39. Choi KH, Joo BS, Sun ST, Park MJ, Son JB, Joo JK, Lee KS. Administration of visfatin during superovulation improves developmental competency of oocytes and fertility potential in aged female mice. Fertil Steril 2012, 97:1234-1241. e3, 10.1016/j.fertnstert.2012.02.032, 22425197.
40. Glister C, Kemp CF, Knight PG. Bone morphogenetic protein (BMP) ligands and receptors in bovine ovarian follicle cells: actions of BMP-4, -6 and -7 on granulosa cells and differential modulation of smad-1 phosphorylation by follistatin. Reproduction 2004, 127:239-254. 10.1530/rep.1.00090, 15056790.
41. Brankin V, Quinn RL, Webb R, Hunter MG. BMP-2 and -6 modulate porcine theca cell function alone and co-cultured with granulosa cells. Domest Anim Endocrinol 2005, 29:593-604. 10.1016/j.domaniend.2005.04.001, 16213992.
42. Kayamori T, Kosaka N, Miyamoto A, Shimizu T. The differential pathways of bone morphogenetic protein (BMP)-4 and -7 in the suppression of the bovine granulosa cell apoptosis. Mol Cell Biochem 2009, 323:161-168. 10.1007/s11010-008-9976-1, 19083154.